Ed Dicks

Author PubWeight™ 208.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations of the BRAF gene in human cancer. Nature 2002 65.42
2 Patterns of somatic mutation in human cancer genomes. Nature 2007 38.41
3 Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature 2004 8.35
4 A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 2009 8.30
5 Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013 8.24
6 Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 2005 7.66
7 Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A 2008 7.22
8 A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res 2006 6.91
9 A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet 2005 6.70
10 Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013 5.58
11 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 4.38
12 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
13 RNA editing of human microRNAs. Genome Biol 2006 4.16
14 Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 2006 4.09
15 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
16 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
17 Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012 3.20
18 Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults. Genes Chromosomes Cancer 2006 2.50
19 Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 2013 2.39
20 Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat Genet 2007 2.35
21 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
22 Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet 2007 2.07
23 X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008 1.95
24 Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 2013 1.88
25 Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. Am J Hum Genet 2006 1.85
26 Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013 1.78
27 Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. Am J Hum Genet 2007 1.73
28 A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet 2013 1.52
29 Fine scale mapping of the breast cancer 16q12 locus. Hum Mol Genet 2010 1.39
30 Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly. Am J Hum Genet 2007 1.26
31 High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparison. Genomics 2006 1.08
32 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
33 Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants. J Med Genet 2013 0.95
34 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77